Stay updated on AVP-786 Long-Term Safety & Efficacy in Alzheimer's Agitation Clinical Trial
Sign up to get notified when there's something new on the AVP-786 Long-Term Safety & Efficacy in Alzheimer's Agitation Clinical Trial page.

Latest updates to the AVP-786 Long-Term Safety & Efficacy in Alzheimer's Agitation Clinical Trial page
- Check4 days agoChange DetectedAn NIH grant/contract identifier for 2017 was added to the study's Other Study ID Numbers. This clarifies government funding attribution for the AVP-786 long-term extension study.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page revision was updated to v3.6.5 from v3.6.4, signaling a minor update to the site. This change does not modify the study information or other user-facing content.SummaryDifference0.0%

- Check39 days agoChange DetectedPage revision updated from v3.6.3 to v3.6.4, representing a minor platform update.SummaryDifference0.0%

- Check60 days agoChange DetectedThe page revision was updated from v3.6.1 to v3.6.3, indicating a new revision of the page. This change reflects an updated revision of the page content or metadata.SummaryDifference0.0%

- Check68 days agoChange DetectedThe page's revision label updated from v3.6.0 to v3.6.1, indicating a small build or document revision. This change is a metadata-level update and does not modify visible content.SummaryDifference0.0%

- Check82 days agoChange DetectedRecruitment status is updated to indicate no participants are being sought, and new guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) are added to help users understand the study record and participate if eligible. A formatting adjustment for the Intervention/Treatment label and a new Revision: v3.6.0 tag are also included.SummaryDifference0.2%

Stay in the know with updates to AVP-786 Long-Term Safety & Efficacy in Alzheimer's Agitation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AVP-786 Long-Term Safety & Efficacy in Alzheimer's Agitation Clinical Trial page.